Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    May 2017

  1. Correction: Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.
    Cancer Res. 2017;77:2770.
    PubMed     Text format    


    April 2017
  2. SANS M, Gharpure KM, Tibshirani R, Zhang J, et al
    Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging.
    Cancer Res. 2017 Apr 17. pii: canres.3044.2016.
    PubMed     Text format     Abstract available



  3. Correction: EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells.
    Cancer Res. 2017;77:2175.
    PubMed     Text format    


  4. WANG L, Shi C, Wright FA, Guo D, et al
    Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment.
    Cancer Res. 2017 Apr 10. pii: canres.3119.2016.
    PubMed     Text format     Abstract available


  5. OSE J, Poole EM, Schock H, Lehtinen M, et al
    Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium.
    Cancer Res. 2017 Apr 5. pii: canres.3322.2016.
    PubMed     Text format     Abstract available



  6. Correction: EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition.
    Cancer Res. 2017;77:1778.
    PubMed     Text format    


    March 2017
  7. TEMKO DP, Cheng YK, Polyak K, Michor F, et al
    Mathematical modeling links pregnancy-associated changes and breast cancer risk.
    Cancer Res. 2017 Mar 30. pii: canres.2504.2016.
    PubMed     Text format     Abstract available


    February 2017
  8. CHEN MW, Yang ST, Chien MH, Hua KT, et al
    The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer.
    Cancer Res. 2017 Feb 16. pii: canres.1115.2016.
    PubMed     Text format     Abstract available


  9. SUNDARAM KM, Zhang Y, Mitra AK, Kouadio JK, et al
    Prolactin receptor-mediated internalization of imaging agents detects epithelial ovarian cancer with enhanced sensitivity and specificity.
    Cancer Res. 2017 Feb 15. pii: canres.1454.2016.
    PubMed     Text format     Abstract available


    January 2017
  10. ZHAO L, Ji G, Le X, Wang C, et al
    Long non-coding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression of ovarian cancer.
    Cancer Res. 2017 Jan 13. pii: canres.1615.2016.
    PubMed     Text format     Abstract available


    December 2016
  11. SAMPSON JN, Falk RT, Schairer C, Moore SC, et al
    Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women.
    Cancer Res. 2016 Dec 23. pii: canres.1717.2016.
    PubMed     Text format     Abstract available


    November 2016
  12. YANG X, Chen G, Li W, Peng C, et al
    Cervical cancer growth is regulated by a c-ABL-PLK1 signaling axis.
    Cancer Res. 2016 Nov 15. pii: canres.1378.2016.
    PubMed     Text format     Abstract available


  13. BAI S, Ingram P, Chen YC, Deng N, et al
    EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells.
    Cancer Res. 2016;76:6396-6409.
    PubMed     Text format     Abstract available


  14. YOKOYAMA Y, Zhu H, Lee JH, Kossenkov AV, et al
    BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.
    Cancer Res. 2016;76:6320-6330.
    PubMed     Text format     Abstract available


  15. IORIO MV, Croce CM
    Commentary on microRNA Fingerprint in Human Epithelial Ovarian Cancer.
    Cancer Res. 2016;76:6143-6145.
    PubMed     Text format    


    October 2016
  16. KANLIKILICER P, Saber M, Bayraktar R, Mitra R, et al
    Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells.
    Cancer Res. 2016 Oct 14. pii: canres.0714.2016.
    PubMed     Text format     Abstract available


    September 2016
  17. CLARK CA, Gupta H, Sareddy GR, Pandeswara S, et al
    Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis and autophagy in ovarian cancer and melanoma.
    Cancer Res. 2016 Sep 26. pii: canres.0258.2016.
    PubMed     Text format     Abstract available


  18. JUNG JG, Shih IM, Park JT, Gerry E, et al
    Ovarian cancer chemoresistance relies on the the stem cell reprogramming factor PBX1.
    Cancer Res. 2016 Sep 2. pii: canres.0980.2016.
    PubMed     Text format     Abstract available


    August 2016
  19. HSU YT, Osmulski P, Wang Y, Huang YW, et al
    EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells that Promote Epithelial-to-Mesenchymal Transition.
    Cancer Res. 2016 Aug 28. pii: canres.0752.2016.
    PubMed     Text format     Abstract available


  20. WALTON J, Blagih J, Ennis D, Leung E, et al
    CRISPR/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high grade serous carcinoma.
    Cancer Res. 2016 Aug 16. pii: canres.1272.2016.
    PubMed     Text format     Abstract available


  21. HAESEN D, Abbasi Asbagh L, Derua R, Hubert A, et al
    Recurrent PPP2R1A mutations in uterine cancer act through a dominant-negative mechanism to promote malignant cell growth.
    Cancer Res. 2016 Aug 2. pii: canres.3342.2015.
    PubMed     Text format     Abstract available


    July 2016
  22. DUGGAN C, Tapsoba JD, Wang CY, McTiernan A, et al
    Dietary Weight Loss and Exercise Effects on Serum Biomarkers of Angiogenesis in Overweight Postmenopausal Women: A Randomized Controlled Trial.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


    June 2016

  23. Correction: Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth.
    Cancer Res. 2016;76:3437.
    PubMed     Text format    


    May 2016
  24. WALCH-RUCKHEIM B, Pahne-Zeppenfeld J, Fischbach J, Wickenhauser C, et al
    STAT3/IRF1 pathway activation sensitizes cervical cancer cells to chemotherapeutic drugs.
    Cancer Res. 2016 May 23. pii: canres.1306.2014.
    PubMed     Text format     Abstract available


  25. KIM SY, Ebbert K, Cordeiro MH, Romero MM, et al
    Constitutive activation of PI3K in oocytes induces ovarian granulosa cell tumors.
    Cancer Res. 2016 May 9. pii: canres.3358.2015.
    PubMed     Text format     Abstract available


  26. DROOG M, Nevedomskaya E, Kim Y, Severson T, et al
    Comparative cistromics reveals genomic crosstalk between FOXA1 and ERalpha in tamoxifen-associated endometrial carcinomas.
    Cancer Res. 2016 May 6. pii: canres.1813.2014.
    PubMed     Text format     Abstract available


    April 2016
  27. FEHRINGER G, Kraft P, Pharoah PD, Eeles RA, et al
    Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.
    Cancer Res. 2016 Apr 20. pii: canres.2980.2015.
    PubMed     Text format     Abstract available


    February 2016
  28. LI M, Kales SC, Ma K, Shoemaker BA, et al
    Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation.
    Cancer Res. 2016;76:561-71.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: